Clara Charleton

Ms. Clara Charleton


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JKJames Mc Keown
James Mc Keown
ABAndrew Jam3s Byrne
Andrew Jam3s Byrne
SBSandra A. Bright
Sandra A. Bright
CCClara Charleton
Clara Charleton
SKShubhangi Kandwal
Shubhangi Kandwal
Mary Jane MeeganMary Jane Meegan
Mary Jane Meegan
Chronic lymphocytic leukemia (CLL) is a malignancy of mature B cells, and it is the most frequent form of leukemia diagnosed in Western countries. It is characterized by the proliferation and accumulation of neoplastic B lymphocytes in the blood, lymph nodes, bone marrow and spleen. We report the synthesis and antiproliferative effects of a series of novel ethanoanthracene compounds in CLL cell lines. Structural modifications were achieved via the Diels–Alder reaction of 9-(2-nitrovinyl)anthracene and 3-(anthracen-9-yl)-1-arylprop-2-en-1-ones (anthracene chalcones) with dienophiles, including maleic anhydride and N-substituted maleimides, to afford a series of 9-(E)-(2-nitrovinyl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-diones, 9-(E)-3-oxo-3-phenylprop-1-en-1-yl)-9,10-dihydro-9,10-[3,4]epipyrroloanthracene-12,14-diones and related compounds. Single-crystal X-ray analysis confirmed the structures of the novel ethanoanthracenes 23f, 23h, 24a, 24g, 25f and 27. The products were evaluated in HG-3 and PGA-1 CLL cell lines (representative of poor and good patient prognosis, respectively). The most potent compounds were identified as 20a, 20f, 23a and 25n with IC50 values in the ranges of 0.17–2.69 µM (HG-3) and 0.35–1.97 µM (PGA-1). The pro-apoptotic effects of the potent compounds 20a, 20f, 23a and 25n were demonstrated in CLL cell lines HG-3 (82–95%) and PGA-1 (87–97%) at 10 µM, with low toxicity (12–16%) observed in healthy-donor peripheral blood mononuclear cells (PBMCs) at concentrations representative of the compounds IC50 values for both the HG-3 and PGA-1 CLL cell lines. The antiproliferative effect of the selected compounds, 20a, 20f, 23a and 25n, was mediated through ROS flux with a marked increase in cell viability upon pretreatment with the antioxidant NAC. 25n also demonstrated sub-micromolar activity in the NCI 60 cancer cell line panel, with a mean GI50 value of 0.245 µM. This ethanoanthracene series of compounds offers potential for the further development of lead structures as novel chemotherapeutics to target CLL.

3 November 2018
Verified
Conference Paper
Open access
Mary Jane MeeganMary Jane Meegan
Mary Jane Meegan
JKJames Mc Keown
James Mc Keown
CCClara Charleton
Clara Charleton
KFKeith Ferris
Keith Ferris
SNSara Noorani
Sara Noorani
NONiamh O'Boyle
Niamh O'Boyle
CLL (Chronic Lymphocytic Leukaemia) is the most common leukaemia in the Western world. Classed as a clonal disorder of mature B-lymphocytes, CLL patient prognoses are broadly subdivided by the mutational status of the Immunoglobulin G Heavy Chain Variable region (IGHV) (with unmutated IGHV holding a better patient prognosis than the wild type variant)1. Structures related to tricyclic and tetracyclic anti-depressants (fluoxetine,maprotiline respectively) have previously been shown to exert potent, selective antiproliferative and pro-apoptotic effects in vitro and were met with marked success in related B cell malignancy cell lines, namely Burkitt’s Lymphoma (BL) cell lines DG-75 and MUTU-12. Based on these preliminary studies, libraries of structurally related novel ethanoanthracene compounds were designed, based on the proven effectiveness of nitrostyrene core moiety derivatives and literature evidence of selective toxicity of chalcone moieties in leukaemic cell lines3. The antiproliferative activity of each compound was determined using Alamar Blue assays on the two types of CLL cell lines: HG-3 and PGA-1, representative of bad and good prognosis respectively. The most promising activity was observed with maleimide dienophile based ethanoanthracene chalcones, particularly at a 10 µM across both cell lines. A ROS (reactive oxygen species) dependant activity was noted as both nitrostyrene and chalcone based analog biological activity markedly decreased on addition of NAC (N- acetyl cysteine) or Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid). References Scarfò, L.; Ferreri, A. J. M.; Ghia, P., Critical Reviews in Oncology/Hematology, 2016, 104, 169-182. Mc Namara, Y. M., Bright, S.A., Byrne, A.J., Williams, D.C., Meegan, M.J., European Journal of Medicinal Chemistry 2014, 71, 333. Zhuang, C.; Zhang, W.; Sheng, C.; Zhang, W.; Xing, C.; Miao, Z., Chemical Reviews, 2017, 117(12):7762-7810.